FIGURE

Figure 4

ID
ZDB-FIG-220131-529
Publication
Hentig et al., 2021 - Prophylactic Activation of Shh Signaling Attenuates TBI-Induced Seizures in Zebrafish by Modulating Glutamate Excitotoxicity through Eaat2a
Other Figures
All Figure Page
Back to All Figure Page
Figure 4

Shh activation combats excitotoxicity and upregulates Eaat2a. Undamaged fish with and without Shh modulation and ceftriaxone treatment were exposed to 5 mM glutamate in fish water (n = 90 fish per control/experimental group). (A) Quantification of time to first seizure, (B) percent of the group to display at least 1 seizure event, and (C) percent of the group that survived for 1 h. (D,E) Expression of Shh component, gli, and excitatory amino acid transporter (eaat) genes by qRT-PCR revealed that purmorphamine increased gli and eaat2a mRNAs in both undamaged telencephalons and cerebellums (n = 3 per control/experimental group, with 5 pooled telencephalons or cerebellums/trial). (F,G) Administration of ceftriaxone increased eaat2a mRNA expression levels without Shh activation in undamaged telencephalons and cerebellums (n = 3 per control/experimental group, with 5 pooled telencephalons or cerebellums/trial). (H) Expression of Eaat2a in the undamaged cerebellum (5 pooled cerebellums per control/experimental group) following either purmorphamine or ceftriaxone treatment was assessed by immunoblot, using GAPDH as a loading control (H, top and lower bands, respectively). Eaat2a protein expression was increased following either purmorphamine or ceftriaxone treatment compared to controls. (I) Expression of eaat2a by qRT-PCR in sTBI fish with either Shh signaling activated, inhibited, or inhibited and cotreated with ceftriaxone at 12 hpi to 14 dpi (n = 3 per control/experimental group, with 5 pooled cerebellums/group). (J) Microdialysis was performed to quantify extracellular glutamate levels in undamaged and sTBI fish with and without Shh modulation and ceftriaxone treatment at 30 min post-injury, 12 and 36 hpi, and 5 dpi (n = 3 per control/experimental group). In panels A-C, the plus sign (+) denotes application of the reagent and the minus sign (-) denotes the absence of the reagent. Grey box denotes period of cyclopamine administration. Statistical analyses were performed with a one-way ANOVA followed by Dunnett’s multiple comparison post hoc test, # p < 0.05, ## p < 0.01.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomedicines